Feels like we're at the inflection point; good organic revenue that should grow at an accelerated pace with the the CPR alliance, Promarker hitting the Latin streets soon and the partnership with Dimerix to explore diagnosis/treatment combo. Throw in the blue sky of a detecting chronic lung disease and other proteomics based diagnostic developments in the longer term, there are a bunch of imminent catalysts. A rerate in the coming months wouldn't be surprising.
Feels like we're at the inflection point; good organic revenue...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
83.5¢ |
Change
-0.035(4.02%) |
Mkt cap ! $112.6M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.0¢ | 83.0¢ | $75.86K | 90.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 15011 | 83.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 84.0¢ | 13041 | 2 |
View Market Depth
| Last trade - 12.11pm 28/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |